A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Clinical trial NCT06996080 · RECRUITING
Trial details
- NCT number
- NCT06996080
- Sponsor
- Kodiak Sciences Inc
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-16
- Primary completion
- 2027-02-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.